Frenkel Topping Group plc
("Frenkel Topping" or "the Company")
Director/PDMR Dealing
Frenkel Topping Group (AIM: FEN), a specialist professional and financial services firm operating in the Personal Injury (PI) Clinical Negligence (CN) space, announces that the wife of Richard Fraser, Chief Executive Officer of the Company, has sold 100,000 ordinary shares of 0.5p each in the capital of the Company ("Ordinary Shares") from her SIPP for tax planning purposes and pursuant to investor demand following the release of the Company's results on 25 April.
Following the sale of these shares Mr. Fraser and persons closely associated ("PCAs") to him will be interested in 1,895,907 Ordinary Shares of the Company, representing approximately 1.68 per cent. of the Company's issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Norma Fraser | ||||
2. | Reason for the Notification | |||||
a) | Position/status | PCA of Richard Fraser, Chief Executive Officer | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Frenkel Topping Group plc | ||||
b) | LEI | 213800I5L3K7AT7A4R20 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument
| Ordinary Shares | ||||
Identification code | GB00B01YXQ71 | |||||
b) | Nature of the transaction | Sale of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: · Aggregated volume · Price |
| ||||
e) | Date of the transaction | 3 May 2022 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.